These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18330008)

  • 1. What is animal experimentation telling us about new drug treatments of status epilepticus?
    Nehlig A
    Epilepsia; 2007; 48 Suppl 8():78-81. PubMed ID: 18330008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
    Brandt C; Potschka H; Löscher W; Ebert U
    Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
    Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
    Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
    Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
    Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium cromoglycate reduces short- and long-term consequences of status epilepticus in rats.
    Valle-Dorado MG; Santana-Gómez CE; Orozco-Suárez SA; Rocha L
    Epilepsy Behav; 2018 Oct; 87():200-206. PubMed ID: 30115604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant and Neuroprotective Effects of Dexmedetomidine on Pilocarpine-Induced Status Epilepticus in Rats Using a Metabolomics Approach.
    Tan X; Tu Z; Han W; Song X; Cheng L; Chen H; Tu S; Li P; Liu W; Jiang L
    Med Sci Monit; 2019 Mar; 25():2066-2078. PubMed ID: 30892279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers.
    Brandt C; Töllner K; Klee R; Bröer S; Löscher W
    Neurobiol Dis; 2015 Mar; 75():78-90. PubMed ID: 25549873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.
    Licko T; Seeger N; Zellinger C; Russmann V; Matagne A; Potschka H
    Epilepsia; 2013 Jul; 54(7):1176-85. PubMed ID: 23614482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in epilepsy.
    Walker M
    Epilepsia; 2007; 48 Suppl 8():66-8. PubMed ID: 18330004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic mechanisms in status epilepticus: role of calcium in neuronal injury and the induction of epileptogenesis.
    DeLorenzo RJ; Sun DA
    Adv Neurol; 2006; 97():187-97. PubMed ID: 16383128
    [No Abstract]   [Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam.
    Rice AC; DeLorenzo RJ
    Neuroscience; 1999; 93(1):117-23. PubMed ID: 10430476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
    FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cerebral peroxisome proliferator-activated receptors gamma exerts neuroprotection by inhibiting oxidative stress following pilocarpine-induced status epilepticus.
    Yu X; Shao XG; Sun H; Li YN; Yang J; Deng YC; Huang YG
    Brain Res; 2008 Mar; 1200():146-58. PubMed ID: 18289512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.
    André V; Rigoulot MA; Koning E; Ferrandon A; Nehlig A
    Epilepsia; 2003 Jul; 44(7):893-903. PubMed ID: 12823571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of self-sustaining seizures and pharmacoresistance during status epilepticus: The receptor trafficking hypothesis revisited.
    Wasterlain CG; Liu H; Naylor DE; Thompson KW; Suchomelova L; Niquet J; Mazarati AM; Baldwin RA
    Epilepsia; 2009 Dec; 50 Suppl 12():16-8. PubMed ID: 19941513
    [No Abstract]   [Full Text] [Related]  

  • 17. Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice.
    Welzel L; Twele F; Schidlitzki A; Töllner K; Klein P; Löscher W
    Epilepsy Res; 2019 Mar; 151():48-66. PubMed ID: 30831337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine.
    Spampanato J; Bealer SL; Smolik M; Dudek FE
    J Pharmacol Exp Ther; 2020 Oct; 375(1):59-68. PubMed ID: 32873622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model.
    Russmann V; Goc J; Boes K; Ongerth T; Salvamoser JD; Siegl C; Potschka H
    Eur J Pharmacol; 2016 Jan; 771():29-39. PubMed ID: 26681545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomycin B attenuates neuronal death via PKA- and PP2B-mediated ERK1/2 activation in the rat hippocampus following status epilepticus.
    Min SJ; Hyun HW; Kang TC
    Brain Res; 2017 Sep; 1670():14-23. PubMed ID: 28601633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.